Skip to content

Taxes Paid at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$774K+176%
Theravance Biopharma logo
Theravance BiopharmaTBPH
-$351K-8,875%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$670K
Zymeworks logo
ZymeworksZYME
$245K-36.7%
ALN
Alnylam PharmaceuticalsALNY
$2.37M-20.2%
Xencor logo
XencorXNCR
$3.01M

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Market cap$746.04M+159%
Enterprise value$785.17M+152%
P/E22.1×
P/S15.4×+8.7×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Reported directly by XOMA Corporation in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesPaidNet.

The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's taxes paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's taxes paid?
XOMA Corporation (XOMA) reported taxes paid of $277K in Q1 2025.
What does taxes paid mean?
Actual cash paid to tax authorities for income taxes during the period — may differ from income tax expense due to timing.